Roche shares pop 4% on $5.3 billion obesity drug deal with Zealand Pharma
Roche has agreed to a $5.3 billion deal with Zealand Pharma to develop the obesity drug candidate petrelintide, including a ...
Friday, October 3, 2025
Tag: Pharmaceuticals
U.S. health regulator pulls up Jagsonpal Pharmaceuticals for manufacturing lapses at API plant
The U.S. health regulator has issued a warning letter to Jagsonpal Pharmaceuticals for significant manufacturing lapses at its Rajasthan-based active ...
Novo Nordisk shares gain 4.5% on fourth-quarter profit beat, Wegovy sales jump
Shares of Novo Nordisk rose 4.5% after reporting a better-than-expected net profit in the fourth quarter, driven by strong demand ...
Swiss pharma giant Novartis posts better-than-expected fourth-quarter sales
Swiss pharmaceutical company Novartis reported better-than-expected sales in Q4, with net sales rising 16% to $13.2 billion, exceeding analyst estimates. ...
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Pharmaceutical companies are optimistic about growth under the Trump administration, with hopes for a pro-business approach focusing on cracking down ...
Novo Nordisk shares pop 10% on early-stage weight loss drug trial results
Shares of Novo Nordisk surged 10% following positive early-stage results for its once weekly amycretin obesity drug, which led to ...
Novo Nordisk shares plunge 19% after disappointing trial results; Lilly jumps in premarket
Shares of Novo Nordisk dropped over 24% after disappointing results in a trial for its CagriSema weight loss drug, which ...
News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.